Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.98
Delayed Data
As of Oct 18
 -0.03 / -1.49%
Today’s Change
1.27
Today|||52-Week Range
7.10
+39.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash18.7M9.8M10.2M11.6M
 
 
 
 
 
Short Term Investment Cash5.2M-8.9M373.2K1.4M
 
 
 
 
 
Cash & Short Term Investments18.8M32.7M23.4M20.3M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses507.2K--501.2K179.5K
 
 
 
 
Other Current Assets0.00731.0K720.6K429.0K
 
 
 
 
Current Assets19.3M33.4M24.7M20.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross645.9K687.2K749.5K758.1K
 
 
 
 
 
Depreciation-580.7K-609.1K-636.6K-669.5K
 
 
 
 
 
Other Assets0.000.000.0030.8K
 
 
Total Assets19.6M33.5M24.8M21.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable251.7K706.8K774.5K0.00
 
 
 
 
Accrued Expenses240.6K1.1M1.6M641.1K
 
 
 
 
 
Other Current Liabilities240.6K1.1M1.6M1.1M
 
 
 
 
 
Other Liabilities933.8K2.5M2.7M1.9M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities5.1M3.9M2.8M1.7M
 
 
 
 
 
Total Liabilities6.9M7.0M6.0M4.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity12.6M26.6M18.8M17.1M
 
 
 
 
 
Total Shareholder Equity12.6M26.6M18.8M17.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.7M17.8M19.7M23.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.